Catalyst Wire Dossier Catalyst Wire Dossier

Opast Tablet

· Yungjin Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opast Tablet, covering 2015-12-22 to 2015-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis [Phase 4]

See pricing